Literature DB >> 17003284

Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and LbetaT2 gonadotropes.

Judith L Turgeon1, Dennis W Waring.   

Abstract

Manipulation of endogenous progesterone receptor (PR) does not produce equivalent physiological effects in mouse and rat pituitary cells. To test whether this may be due in part to difference in PR isoform expression, we examined hormonally regulated pituitary PR-A and PR-B mRNA levels using quantitative real-time PCR. The LbetaT2 mouse gonadotrope line or pituitary cells from adult, ovariectomized rats or mice were cultured with or without 0.2 nM 17beta-estradiol (E(2)) for 3 days. PR-A was the predominant form expressed for all groups. For mouse cells, E(2) led to an increase in both isoforms without a change in the A:B ratio; for rat cells, the PR-B response to E(2) was more robust resulting in a decrease in the A:B ratio. Exposure of E(2)-treated pituitary cells to 200 nM progesterone for 6 h decreased both PR-A and PR-B levels in rat cells, but had no effect on PR isoform expression in mouse cells even when exposure was extended to 12 h. The low level of PR expression found in LbetaT2 gonadotropes was unaffected by E(2), alone or with progesterone. The weak PR expression and lack of responsiveness of LbetaT2 cells cannot be explained by a male phenotype as was shown by the more than tenfold higher PR mRNA level in primary cultures of male mouse pituitary cells, which responded to E(2) stimulation with a proportional increase in PR isoforms similar to female cells. Functionally, E(2)-stimulated changes in PR mRNA isoform ratios in rat, mouse or LbetaT2 cells correlated with the degree of progesterone augmentation of GnRH-stimulated LH secretion in these models. These results are consistent with the hypothesis that robust GnRH priming and progesterone augmentation of LH secretion in the rat compared to these events in the mouse are a consequence, in part, of differences in the E(2)-modulated ratio of PR isoforms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003284     DOI: 10.1677/joe.1.06923

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  Optimized amplification and single-cell analysis identify GnRH-mediated activation of Rap1b in primary rat gonadotropes.

Authors:  Tony Yuen; Soon Gang Choi; Hanna Pincas; Dennis W Waring; Stuart C Sealfon; Judith L Turgeon
Journal:  Mol Cell Endocrinol       Date:  2011-11-25       Impact factor: 4.102

Review 2.  Progestin receptor subtypes in the brain: the known and the unknown.

Authors:  Shaila Mani
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

3.  Classical and membrane-initiated estrogen signaling in an in vitro model of anterior hypothalamic kisspeptin neurons.

Authors:  Melinda A Mittelman-Smith; Angela M Wong; Anupama S Q Kathiresan; Paul E Micevych
Journal:  Endocrinology       Date:  2015-03-02       Impact factor: 4.736

4.  Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

Authors:  Paola A Rojas; María May; Gonzalo R Sequeira; Andrés Elia; Michelle Alvarez; Paula Martínez; Pedro Gonzalez; Stephen Hewitt; Xiaping He; Charles M Perou; Alfredo Molinolo; Luz Gibbons; Martin C Abba; Hugo Gass; Claudia Lanari
Journal:  J Natl Cancer Inst       Date:  2017-07-01       Impact factor: 13.506

5.  Rapid effect of GNRH1 on follicle-stimulating hormone beta gene expression in LbetaT2 mouse pituitary cells requires the progesterone receptor.

Authors:  Beum-Soo An; Song Ling Poon; Wai-Kin So; Geoffrey L Hammond; Peter C K Leung
Journal:  Biol Reprod       Date:  2009-04-08       Impact factor: 4.285

6.  Synergistic induction of follicle-stimulating hormone beta-subunit gene expression by gonadal steroid hormone receptors and Smad proteins.

Authors:  Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

7.  Progesterone Inhibits basal and gonadotropin-releasing hormone induction of luteinizing hormone beta-subunit gene expression.

Authors:  Varykina G Thackray; Jennifer L Hunnicutt; Aisha K Memon; Yasmin Ghochani; Pamela L Mellon
Journal:  Endocrinology       Date:  2008-12-23       Impact factor: 4.736

8.  AMP-activated protein kinase activation reduces the transcriptional activity of the murine luteinizing hormone β-subunit gene.

Authors:  Ryutaro Moriyama; Koichi Iwamoto; Teruki Hagiwara; Saishu Yoshida; Takako Kato; Yukio Kato
Journal:  J Reprod Dev       Date:  2019-12-09       Impact factor: 2.214

9.  Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee.

Authors:  Barbara D Boyan; David A Hart; Roger M Enoka; Daniel P Nicolella; Eileen Resnick; Karen J Berkley; Kathleen A Sluka; C Kent Kwoh; Laura L Tosi; Mary I O'Connor; Richard D Coutts; Wendy M Kohrt
Journal:  Biol Sex Differ       Date:  2013-02-04       Impact factor: 5.027

10.  Limbic progesterone receptor activity enhances neuronal excitability and seizures.

Authors:  Shinnosuke Shiono; Huayu Sun; Tamal Batabyal; Aleksandra Labuz; John Williamson; Jaideep Kapur; Suchitra Joshi
Journal:  Epilepsia       Date:  2021-06-24       Impact factor: 6.740

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.